DarioHealth Corp. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
DarioHealth Corp. (DRIO) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $549.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-08-11
- DarioHealth Corp. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- DarioHealth Corp. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-09-30 was $0.00.
- DarioHealth Corp. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-06-30 was $400.00K.
- DarioHealth Corp. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-03-31 was $28.00K, a 0.00% change year-over-year.
- DarioHealth Corp. right-of-use asset obtained in exchange for operating lease liability for fiscal 2025 was $73.00K, a 82.94% decline from fiscal 2024.
- DarioHealth Corp. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $428.00K, a 214.71% increase from fiscal 2023.
- DarioHealth Corp. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $136.00K, a 89.28% decline from fiscal 2022.
- DarioHealth Corp. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $1.27M, a 2166.07% increase from fiscal 2021.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $549.00K 10-Q · filed 2026-08-11 | |||
| 2025-12-31 | $73.00K 10-K · filed 2026-03-19 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $0.00 derived: sum of 2 quarters · filed 2026-03-19 | $400.00K derived: sum of 3 quarters · filed 2026-03-19 | $428.00K 10-K · filed 2026-03-19 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $400.00K derived: sum of 2 quarters · filed 2025-11-13 | $428.00K 10-Q · filed 2025-11-13 | $550.00K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $400.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $428.00K 10-Q · filed 2025-08-12 | $550.00K derived: sum of 3 quarters · filed 2025-08-12 | $550.00K derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $28.00K 10-Q · filed 2025-05-14 | $150.00K derived: sum of 2 quarters · filed 2025-05-14 | $150.00K derived: sum of 3 quarters · filed 2025-05-14 | $136.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10 | $122.00K derived: sum of 2 quarters · filed 2025-03-10 | $108.00K derived: sum of 3 quarters · filed 2025-03-10 | $136.00K 10-K · filed 2025-03-10 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$14.00K derived: sum of 2 quarters · filed 2024-11-07 | $14.00K 10-Q · filed 2024-11-07 | $106.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $14.00K 10-Q · filed 2024-08-08 | $106.00K derived: sum of 3 quarters · filed 2024-08-08 | $1.23M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $28.00K 10-Q · filed 2024-05-15 | $120.00K derived: sum of 2 quarters · filed 2024-05-15 | $1.24M derived: sum of 3 quarters · filed 2024-05-15 | $1.24M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $1.21M derived: sum of 2 quarters · filed 2024-03-28 | $1.21M derived: sum of 3 quarters · filed 2024-03-28 | $1.27M 10-K · filed 2024-03-28 |
| 2022-09-30 | $1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.12M derived: sum of 2 quarters · filed 2023-11-02 | $1.18M 10-Q · filed 2023-11-02 | $1.15M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $58.00K 10-Q · filed 2023-08-10 | $34.00K derived: sum of 3 quarters · filed 2023-08-10 | |
| 2022-03-31 | $58.00K 10-Q · filed 2023-05-11 | $34.00K derived: sum of 2 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $56.00K 10-K · filed 2022-03-22 | ||
| 2021-09-30 | $80.00K 10-Q · filed 2022-11-14 | |||
| 2020-12-31 | $25.00K 10-K · filed 2021-03-09 | |||
| 2019-12-31 | -$737.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | -$634.00K derived: sum of 2 quarters · filed 2020-03-17 | -$634.00K derived: sum of 3 quarters · filed 2020-03-17 | $244.00K 10-K · filed 2020-03-17 |
| 2019-09-30 | $103.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28 | $103.00K derived: sum of 2 quarters · filed 2019-10-28 | $981.00K 10-Q · filed 2019-10-28 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $878.00K 10-Q · filed 2019-08-13 | ||
| 2019-03-31 | $878.00K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |